Clinical Trials Browser

Has results × Celecoxib × Head & Neck × Clear all

NCT04162873 2025-02-12

Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Phase 2 Terminated

13 enrolled 36 charts

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms

NCT00970502 2017-04-10

Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer

Phase 1/2 Completed

15 enrolled 16 charts

Head and Neck Neoplasms, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT00698204 2014-06-05

Cox-2 Inhibition in Radiation-induced Oral Mucositis

Phase 2 Completed

43 enrolled 10 charts

Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT00581971 2013-04-25

RAD0201

Phase 1/2 Completed

30 enrolled 8 charts

Head and Neck Neoplasms, Neoplasms

NCT00527982 2012-12-06

Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer

Phase 2 Terminated

1 enrolled 2 charts

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms

NCT00592319 2012-08-31

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

Phase 2 Terminated

10 enrolled 6 charts

Laryngeal papillomatosis, Papilloma